What Happened?
Seattle, WA-based Umoja-Biopharma Appointed Andy Scharenberg as Chief Executive Officer
About the Company
Umoja is developing a new approach to cancer therapy that retools a patient`s immune system in vivo, enhancing the body`s natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.
About the Person
Andy Scharenberg is Chief Executive Officer at Umoja Biopharma. Previously, Andy held various senior HR leadership roles in the industry.
Info Source
News
Short Profile